VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,674 | -10.6% | 4,187 | 0.0% | 0.08% | -6.7% |
| Q2 2023 | $126,073 | -6.9% | 4,187 | 0.0% | 0.09% | -11.9% |
| Q1 2023 | $135,452 | +12.9% | 4,187 | 0.0% | 0.10% | +9.8% |
| Q4 2022 | $120,001 | +21.2% | 4,187 | +1.7% | 0.09% | +15.0% |
| Q3 2022 | $99,000 | -12.4% | 4,119 | 0.0% | 0.08% | -2.4% |
| Q2 2022 | $113,000 | -28.5% | 4,119 | 0.0% | 0.08% | -7.9% |
| Q1 2022 | $158,000 | +19.7% | 4,119 | 0.0% | 0.09% | +27.1% |
| Q4 2021 | $132,000 | +4.8% | 4,119 | -3.4% | 0.07% | -5.4% |
| Q3 2021 | $126,000 | -29.6% | 4,264 | -19.1% | 0.07% | -26.0% |
| Q2 2021 | $179,000 | -2.7% | 5,269 | -7.1% | 0.10% | -11.5% |
| Q1 2021 | $184,000 | -56.0% | 5,671 | -51.2% | 0.11% | -24.2% |
| Q4 2020 | $418,000 | – | 11,626 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |